title: [Value of intrathecal baclofen in the treatment of spastic cerebral palsy].
abstract: Spasticity is the most common movement disorder in cerebral palsy. Cerebral spasticity has traditionally been treated with physical therapy and orthopedic surgery. Oral medications have been used with limited success. Intrathecal administration of baclofen may be a valuable alternative in selected patients. We comment the patient management and clinical practice guidelines on the use of intrathecal baclofen for the treatment of spasticity.
authors.affiliation: Unitat Integrada Clínic-Sant Joan de Déu, Esplugues de Llobregat, España. annasans@hsjdbcn.org
authors.forename: A
authors.initials: A
authors.lastname: Sans
mesh_terms: D001418:Baclofen / Q000008:administration & dosage*; D002547:Cerebral Palsy / Q000188:drug therapy*; D002648:Child; D004867:Equipment Design; D018755:GABA Agonists / Q000008:administration & dosage*; D006801:Humans; D007260:Infusion Pumps; D007263:Infusions, Parenteral; D013131:Spine
chemical_list: D018755:GABA Agonists; D001418:Baclofen